CBLL (CeriBell) Common Stock : $0.04 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is CeriBell Common Stock?

CeriBell's quarterly common stock increased from Jun. 2024 ($0.01 Mil) to Sep. 2024 ($0.01 Mil) and increased from Sep. 2024 ($0.01 Mil) to Dec. 2024 ($0.04 Mil).

CeriBell's annual common stock stayed the same from Dec. 2022 ($0.01 Mil) to Dec. 2023 ($0.01 Mil) but then increased from Dec. 2023 ($0.01 Mil) to Dec. 2024 ($0.04 Mil).

CeriBell Common Stock Historical Data

The historical data trend for CeriBell's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CeriBell Common Stock Chart

CeriBell Annual Data

Trend

Dec22

Dec23

Dec24

Common Stock

0.01

0.04

CeriBell Quarterly Data
	Dec22	Sep23	Dec23	Jun24	Sep24	Dec24
Common Stock	Get a 7-Day Free Trial			-	0.01	0.01	0.01	0.04

CeriBell Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

CeriBell Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CeriBell Inc (NAS:CBLL) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

360 N. Pastoria Avenue, Sunnyvale, CA, USA, 94085

Website

https://www.ceribell.com

CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.